Expiration | Code | ||
---|---|---|---|
aflibercept, Eylea, Regeneron Pharmaceuticals, Inc. | |||
2030-02-08 | Orphan excl. |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Colorectal neoplasms | D015179 | — | — | 3 | 19 | 5 | — | 1 | 25 |
Neoplasms | D009369 | — | C80 | 8 | 4 | 3 | — | — | 14 |
Neoplasm metastasis | D009362 | EFO_0009708 | — | 1 | 2 | 3 | — | — | 5 |
Lung neoplasms | D008175 | — | C34.90 | 1 | 2 | 1 | — | — | 3 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | — | 3 | 1 | — | — | 3 |
Carcinoma | D002277 | — | C80.0 | 1 | 1 | 1 | — | — | 2 |
Non-small-cell lung carcinoma | D002289 | — | — | 1 | 1 | 1 | — | — | 2 |
Ascites | D001201 | — | R18 | — | 2 | 1 | — | — | 2 |
Prostatic neoplasms | D011471 | — | C61 | — | — | 1 | — | — | 1 |
Liver neoplasms | D008113 | EFO_1001513 | C22.0 | — | 1 | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Adenocarcinoma | D000230 | — | — | — | 3 | — | — | — | 3 |
Rectal neoplasms | D012004 | — | — | — | 3 | — | — | — | 3 |
Lung diseases | D008171 | EFO_0003818 | J98.4 | — | 1 | — | — | — | 1 |
Adenocarcinoma of lung | D000077192 | — | — | — | 1 | — | — | — | 1 |
Ovarian epithelial carcinoma | D000077216 | — | — | — | 1 | — | — | — | 1 |
Sigmoid neoplasms | D012811 | — | C18.7 | — | 1 | — | — | — | 1 |
Mucinous adenocarcinoma | D002288 | — | — | — | 1 | — | — | — | 1 |
Colonic neoplasms | D003110 | — | C18 | — | 1 | — | — | — | 1 |
Cystadenocarcinoma | D003536 | — | — | — | 1 | — | — | — | 1 |
Melanoma | D008545 | — | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Non-hodgkin lymphoma | D008228 | — | C85.9 | 1 | — | — | — | — | 1 |
Lymphoma | D008223 | — | C85.9 | 1 | — | — | — | — | 1 |
B-cell lymphoma | D016393 | — | — | 1 | — | — | — | — | 1 |
Drug common name | Aflibercept |
INN | aflibercept |
Description | Aflibercept (immunoadhesin) |
Classification | Protein |
Drug class | receptor molecules or membrane ligands, natural, modified or modified: vascular endothelial growth factor (VEGF) receptors |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL1742982 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | DB08885 |
UNII ID | 15C2VL427D (ChemIDplus, GSRS) |